Asset
ROLUPERIDONE HYDROCHLORIDE
Minerva Neurosciences Inc Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03072056 | phase1 | completed | 2017-01-09 | 2017-07-07 | Minerva Neurosciences | A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers |
| NCT03038646 | phase1 | completed | 2016-11-30 | 2017-04-20 | Minerva Neurosciences | A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects |
| NCT02232529 | phase1 | completed | 2014-09-01 | 2015-02-01 | Minerva Neurosciences | Pharmacokinetic Study of MIN-101 in Healthy Subjects |
FDA applications (0)
This company has no applications containing this asset.